Works matching DE "DRUG laws"

Results: 3311

THE REASON FOR THE SNEEZING: ORAL PHENYLEPHRINE AND THE FDA'S FOCUS ON SAFETY AT THE EXPENSE OF EFFECTIVENESS.

Published in:

Alabama Law Review, 2025, v. 76, n. 3, p. 623

By:

Hall, Daniel

Publication type:

Article

Correction to: A single upstream mutation of whiB7 underlies amikacin and clarithromycin resistance in Mycobacterium abscessusFree.

Published in:: 2025
Publication type:: Correction Notice

Addiction Lives: Shekhar Saxena.

Published in:

Addiction, 2025, v. 120, n. 7, p. 1484, doi. 10.1111/add.70034

By:

Berridge, Virginia

Publication type:

Article

Pharmacopoeias, Drug Regulation, and Empires: Making Medicines Official in Britain's Imperial World, 1618–1968.

Published in:

2025

By:

Beckett, Abigail

Publication type:

Book Review

Scoping review on regulation, implementation and postmarket surveillance of medical devices.

Published in:

PLoS ONE, 2025, v. 20, n. 5, p. 1, doi. 10.1371/journal.pone.0325250

By:

Damkjær, Mathias;
Elkjær, Mia;
Hróbjartsson, Asbjørn;
Schroll, Jeppe B.

Publication type:

Article

NCCN Guidelines for NHL, Kidney Cancer Updated With New Drugs.

Published in:: Oncology (08909091), 2009, v. 23, n. 14, p. 1221
Publication type:: Article

FDA Guidances for Early Human Testing of New Drugs.

Published in:: Oncology (08909091), 2006, v. 20, n. 4, p. 325
Publication type:: Article

Regulatory Property: The New IP.

Published in:

Columbia Journal of Law & the Arts, 2016, v. 40, n. 1, p. 53

By:

Feldmanv, Robin

Publication type:

Article

IMAGING PEOPLE WHO USE DRUGS: HOW PARLIAMENTARY ACTORS PICTURE AND TELL STORIES ABOUT THE SUBJECTS OF DRUG LAW REFORM.

Published in:

Australasian Drama Studies, 2024, n. 84, p. 221

By:

MULCAHY, SEAN;
SEEAR, KATE

Publication type:

Article

Funding orphan medicinal products beyond price: sustaining an ecosystem.

Published in:

2019

By:

de Sola-Morales, Oriol

Publication type:

Editorial

Competitive pricing within pharmaceutical classes: evidence on 'follow-on' drugs in Germany 1993-2008.

Published in:

European Journal of Health Economics, 2015, v. 16, n. 1, p. 73, doi. 10.1007/s10198-013-0555-3

By:

Mueller, Michael;
Frenzel, Alexander

Publication type:

Article

Early benefit assessment (EBA) in Germany: analysing decisions 18 months after introducing the new AMNOG legislation.

Published in:

European Journal of Health Economics, 2014, v. 15, n. 6, p. 577, doi. 10.1007/s10198-013-0495-y

By:

Ruof, Jörg;
Schwartz, Friedrich;
Schulenburg, J.-Matthias;
Dintsios, Charalabos-Markos

Publication type:

Article

Psychotropic Drugs Evaluated in the Context of Narcotic Drugs According to the New Turkish Criminal Law.

Published in:: Klinik Psikofarmakoloji Bulteni, 2010, v. 20, n. 4, p. 314, doi. 10.1080/10177833.2010.11790678
Publication type:: Article

Sürücülerde Alkol Dıflı Madde Kullanımının Saptanması: Neden? Nasıl? Nerede?

Published in:

Klinik Psikofarmakoloji Bulteni, 2008, v. 18, n. 3, p. 201

By:

Akgür, Serap A.;
Altıntoprak, A. Ender;
Yüncü, Zeki;
Çoşkunol, Hakan

Publication type:

Article

The Role of Research Evidence in Drug Policy Development in Australia.

Published in:

Politicka Misao: Croatian Political Science Review, 2011, v. 48, n. 5, p. 141

By:

Ritter, Alison

Publication type:

Article

A word of caution.

Published in:

Indian Journal of Plastic Surgery, 2015, v. 48, n. 2, p. 215, doi. 10.4103/0970-0358.163067

By:

Arolkar, Satish

Publication type:

Article

PSYCHEDELICS : A TEST CASE FOR THE LIBERTARIAN.

Published in:

Political Quarterly, 1981, v. 52, n. 2, p. 225, doi. 10.1111/j.1467-923X.1981.tb02799.x

By:

Mishan, E. J.

Publication type:

Article

John Arbuthnot on the Regulation of Drugs and Medicines.

Published in:: Population & Development Review, 2012, v. 38, n. 3, p. 547, doi. 10.1111/j.1728-4457.2012.00516.x
Publication type:: Article

STAKEHOLDER ENGAGEMENT IN PHARMACEUTICAL REGULATION: CONNECTING TECHNICAL EXPERTISE AND LAY KNOWLEDGE IN RISK MONITORING.

Published in:

Public Administration, 2013, v. 91, n. 3, p. 696, doi. 10.1111/padm.12027

By:

MEIJER, ALBERT;
BOON, WOUTER;
MOORS, ELLEN

Publication type:

Article

THE INEXORABLE RISE IN THE UK NHS DRUGS BILL: RECENT POLICIES, FUTURE PROSPECTS.

Published in:

Public Administration, 1996, v. 74, n. 3, p. 393, doi. 10.1111/j.1467-9299.1996.tb00877.x

By:

Earl-Slater, Alan;
Bradley, Colin

Publication type:

Article

Drug Safety Dominates DIA.

Published in:

Bio-IT World, 2005, v. 4, n. 8, p. 30

By:

Uehling, Mark D.

Publication type:

Article

GMP Compliance Goes Digital.

Published in:

Bio-IT World, 2005, v. 4, n. 4, p. 52

By:

Salamone, Salvatore

Publication type:

Article

PDMA Compliance in 12 Steps.

Published in:

Bio-IT World, 2004, v. 3, n. 1, p. 44

By:

DePompa, Barbara

Publication type:

Article

Towards Photochromic Azobenzene‐Based Inhibitors for Tryptophan Synthase.

Published in:

Chemistry - A European Journal, 2021, v. 27, n. 7, p. 2439, doi. 10.1002/chem.202004061

By:

Simeth, Nadja A.;
Kinateder, Thomas;
Rajendran, Chitra;
Nazet, Julian;
Merkl, Rainer;
Sterner, Reinhard;
König, Burkhard;
Kneuttinger, Andrea C.

Publication type:

Article

Front Cover Image, Volume 45, Issue 1.

Published in:

Medicinal Research Reviews, 2025, v. 45, n. 1, p. i, doi. 10.1002/med.22094

By:

Wang, Jinyi;
Zhou, Tingting

Publication type:

Article

Quality, efficacy, safety—it is not enough!

Published in:

European Journal of Clinical Pharmacology, 2021, v. 77, n. 9, p. 1425, doi. 10.1007/s00228-021-03110-3

By:

Garattini, Silvio

Publication type:

Article

Removal of the EMA orphan designation upon request of the sponsor: cui prodest?

Published in:

European Journal of Clinical Pharmacology, 2021, v. 77, n. 7, p. 1057, doi. 10.1007/s00228-021-03096-y

By:

Montanaro, Nicola;
Bonaldo, Giulia;
Motola, Domenico

Publication type:

Article

Impact of changes in controlled drugs legislation on benzodiazepine receptor agonist prescribing in Ireland: a repeated cross-sectional study.

Published in:

European Journal of Clinical Pharmacology, 2021, v. 77, n. 6, p. 903, doi. 10.1007/s00228-020-03063-z

By:

Cadogan, Cathal A.;
Bradley, Colin P.;
Bennett, Kathleen

Publication type:

Article

Clinical evidence supporting the marketing authorization of biosimilars in Europe.

Published in:

European Journal of Clinical Pharmacology, 2020, v. 76, n. 4, p. 557, doi. 10.1007/s00228-019-02805-y

By:

Allocati, Eleonora;
Bertele', Vittorio;
Gerardi, Chiara;
Garattini, Silvio;
Banzi, Rita

Publication type:

Article

Consequences of the new zolpidem prescription regulations: a cohort study from the French national healthcare database.

Published in:

European Journal of Clinical Pharmacology, 2020, v. 76, n. 1, p. 89, doi. 10.1007/s00228-019-02737-7

By:

Touchard, J.;
Sabatier, P.;
Airagnes, G.;
Berdot, S.;
Sabatier, B.

Publication type:

Article

Presentations to the emergency department with non-medical use of benzodiazepines and Z-drugs: profiling and relation to sales data.

Published in:

European Journal of Clinical Pharmacology, 2019, v. 75, n. 1, p. 77, doi. 10.1007/s00228-018-2550-1

By:

Lyphout, C.;
Yates, C.;
Margolin, Z. R.;
Dargan, P. I.;
Dines, A. M.;
Heyerdahl, F.;
Hovda, K. E.;
Giraudon, I.;
Bucher-Bartelson, B.;
Green, J. L.;
Euro-DEN Research Group;
Wood, D. M.

Publication type:

Article

Regulation of biosimilar medicines and current perspectives on interchangeability and policy.

Published in:

European Journal of Clinical Pharmacology, 2019, v. 75, n. 1, p. 1, doi. 10.1007/s00228-018-2542-1

By:

O'Callaghan, J.;
Barry, S. P.;
Bermingham, M.;
Morris, J. M.;
Griffin, B. T.

Publication type:

Article

The race for drug approvals: hasten slowly?

Published in:

European Journal of Clinical Pharmacology, 2018, v. 74, n. 9, p. 1197, doi. 10.1007/s00228-018-2490-9

By:

Braillon, Alain

Publication type:

Article

Response to the letter to the Editor regarding Zeukeng et al.’s article A comparison of new drugs approved by the FDA, the EMA, and Swissmedic: an assessment of the international harmonization of drugs.

Published in:

European Journal of Clinical Pharmacology, 2018, v. 74, n. 9, p. 1199, doi. 10.1007/s00228-018-2486-5

By:

Zeukeng, Minette-Joëlle;
Seoane-Vazquez, Enrique;
Bonnabry, Pascal

Publication type:

Article

The patient’s safety and access to experimental drugs after the termination of clinical trials: regulations and trends.

Published in:

European Journal of Clinical Pharmacology, 2018, v. 74, n. 8, p. 1001, doi. 10.1007/s00228-018-2474-9

By:

da Silva, Ricardo Eccard;
Amato, Angélica Amorim;
Sousa, Thiago do Rego;
de Carvalho, Marta Rodrigues;
Novaes, Maria Rita Carvalho Garbi

Publication type:

Article

From prescription-only (Rx) to over-the-counter (OTC) status in Germany 2006-2015: pharmacological perspectives on regulatory decisions.

Published in:

European Journal of Clinical Pharmacology, 2017, v. 73, n. 7, p. 901, doi. 10.1007/s00228-017-2240-4

By:

Barrenberg, Eva;
Garbe, Edeltraut

Publication type:

Article

Six-year activity on approval of compassionate use of medicines by the Ethics Committee of the University Hospital of Bologna (Italy): time to update rules and recommendations.

Published in:

European Journal of Clinical Pharmacology, 2017, v. 73, n. 4, p. 479, doi. 10.1007/s00228-016-2186-y

By:

Montanaro, Nicola;
Melis, Mauro;
Proni, Stefania;
Chiabrando, Giacomo;
Motola, Domenico

Publication type:

Article

An analysis of marketing authorisation applications via the mutual recognition and decentralised procedures in Europe.

Published in:

European Journal of Clinical Pharmacology, 2015, v. 71, n. 10, p. 1237, doi. 10.1007/s00228-015-1904-1

By:

Ebbers, Hans;
Langedijk, Joris;
Bouvy, Jacoline;
Hoekman, Jarno;
Boon, Wouter;
Jong, Jean;
Bruin, Marie

Publication type:

Article

Sex as a variable in medicines assessment reports for licensing in the European Union. Can gender bias be excluded?

Published in:

European Journal of Clinical Pharmacology, 2014, v. 70, n. 5, p. 519, doi. 10.1007/s00228-014-1646-5

By:

Laguna-Goya, N.;
Andres-Trelles, F.

Publication type:

Article

Orphan drugs, orphan diseases. The first decade of orphan drug legislation in the EU.

Published in:

European Journal of Clinical Pharmacology, 2013, v. 69, n. 4, p. 1009, doi. 10.1007/s00228-012-1423-2

By:

Joppi, Roberta;
Bertele', Vittorio;
Garattini, Silvio

Publication type:

Article

The status of paediatric medicines initiatives around the world-what has happened and what has not?

Published in:

European Journal of Clinical Pharmacology, 2012, v. 68, n. 1, p. 1, doi. 10.1007/s00228-011-1089-1

By:

Hoppu, Kalle;
Anabwani, Gabriel;
Garcia-Bournissen, Facundo;
Gazarian, Madlen;
Kearns, Gregory;
Nakamura, Hidefumi;
Peterson, Robert;
Sri Ranganathan, Shalini;
Wildt, Saskia

Publication type:

Article

Off-label and unlicensed medicine use and adverse drug reactions in children: a narrative review of the literature.

Published in:

European Journal of Clinical Pharmacology, 2012, v. 68, n. 1, p. 21, doi. 10.1007/s00228-011-1097-1

By:

Mason, Jennifer;
Pirmohamed, Munir;
Nunn, Tony

Publication type:

Article

Anything new in EU pharmacovigilance?

Published in:

2011

By:

Garattini, Silvio;
Bertele', Vittorio

Publication type:

Opinion

Looking at EU pharmacovigilance.

Published in:

European Journal of Clinical Pharmacology, 2011, v. 67, n. 11, p. 1201, doi. 10.1007/s00228-011-1074-8

By:

Herxheimer, Andrew

Publication type:

Article

Are traditional NSAIDs prescribed appropriately among French elderly with osteoarthritis? Results from the CADEUS cohort.

Published in:

European Journal of Clinical Pharmacology, 2011, v. 67, n. 8, p. 833, doi. 10.1007/s00228-011-1015-6

By:

Gulmez, Sinem;
Droz-Perroteau, Cécile;
Lassalle, Régis;
Blin, Patrick;
Bégaud, Bernard;
Rossignol, Michel;
Moore, Nicholas;
Fourrier-Réglat, Annie

Publication type:

Article

Three years of paediatric regulation in the European Union.

Published in:

European Journal of Clinical Pharmacology, 2011, v. 67, n. 3, p. 245, doi. 10.1007/s00228-011-0997-4

By:

Olski, Thorsten;
Lampus, Simona;
Gherarducci, Giulia;
Saint Raymond, Agnes

Publication type:

Article

Paediatric investigation plans for pain: painfully slow!

Published in:

European Journal of Clinical Pharmacology, 2010, v. 66, n. 11, p. 1091, doi. 10.1007/s00228-010-0886-2

By:

Davies, Elin;
Ollivier, Cecile;
Saint Raymond, Agnes

Publication type:

Article

Risk Management Plans: are they a tool for improving drug safety?

Published in:

European Journal of Clinical Pharmacology, 2010, v. 66, n. 8, p. 785, doi. 10.1007/s00228-010-0848-8

By:

Frau, Serena;
Font Pous, Maria;
Luppino, Maria;
Conforti, Anita

Publication type:

Article

Predictors of orphan drug approval in the European Union.

Published in:

European Journal of Clinical Pharmacology, 2008, v. 64, n. 5, p. 545, doi. 10.1007/s00228-007-0454-6

By:

Heemstra, Harald E.;
de Vrueh, Remco L.;
van Weely, Sonja;
Büller, Hans A.;
Leufkens, Hubert G. M.

Publication type:

Article

Hims & Hers Super Bowl Ad for Semaglutide "Nothing Short of Reckless," Says Partnership for Safe Medicines.

Published in:

Patient Care (Online), 2025, p. 6

By:

Halsey, Grace

Publication type:

Article